Antiretroviral News and Research

RSS

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.

16 Dec 2021

UTEP to develop new initiative to reduce HIV in people who use drugs in the El Paso-Ciudad Juárez border

The University of Texas at El Paso will develop a sustainable public health intervention to suppress human immunodeficiency virus (HIV) in people who use drugs in the El Paso-Ciudad Juárez border region to help slow the spread of HIV.

11 Dec 2021

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.

10 Dec 2021

Immune responses against SARS-CoV-2 Delta variant after BNT162b2 vaccination in people living with HIV

Researchers from Sorbonne Universite have been investigating the effect of the BNT162b2 mRNA vaccine on HIV-positive individuals.

9 Dec 2021

Children and other patients in Africa missed vital medical appointments due to COVID-19

Patients seeking treatment for HIV, malaria, tuberculosis, maternal and child health services missed vital appointments because of the pressures COVID-19 put on Africa's health systems, new research has found.

2 Dec 2021

Study analyzes global COVID-19 vaccination rates among people living with HIV

COVID-19 vaccination is especially important for immunocompromised individuals, such as people living with HIV, who face higher risks of developing severe symptoms and dying from COVID-19.

1 Dec 2021

WHO recommends the use of first long-acting option to protect women from HIV

The first long-acting option to protect women from HIV, proven to reduce women's HIV risk, has been recommended for use by the World Health Organization.

1 Dec 2021

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

A new study uncovered large and persistent disparities by sex and age in the uptake of a preferred HIV medication in low- and middle-income countries, potentially subjecting some women to worse HIV treatment outcomes if the situation is not corrected quickly.

30 Nov 2021

Scientists identify a new therapeutic target for HIV

Scientists in Montreal and London have identified the key role played by transcription factorRORC2 in HIV infection: the molecule attaches itself to parts of the virus's genome yet doesn't prevent it from replicating.

30 Nov 2021

Substantial efforts needed to help people with HIV achieve durable viral suppression, study suggests

Among people with HIV worldwide who are receiving antiretroviral therapy (ART), adults are getting closer to the global target of 95% achieving viral suppression, but progress among children and adolescents is lagging and long-term viral suppression among all groups remains a challenge.

30 Nov 2021

Research finds low global HIV viral suppression rates among children and adolescents

Globally, less than two thirds of children living with HIV who are taking treatment are 'virally suppressed', according to new research from UNSW Sydney's Kirby Institute and the global IeDEA consortium, published today in The Lancet HIV.

30 Nov 2021

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

A randomized trial found that video-based, telehealth-delivered exercise and weight loss programs with online educational support improved pain and function in people with knee osteoarthritis and overweight or obesity.

30 Nov 2021

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

30 Nov 2021

Improving access to health care is key to reducing HIV incidence

Many patients living with HIV in rural Africa are not receiving regular treatment, despite recent efforts to increase access to health care across the continent.

30 Nov 2021

Time of starting antiretroviral therapy can influence tumor development In HIV patients

HIV patients have an increased risk of developing skin and mucosal cancers, even though HIV is no longer detectable in their blood due to antiretroviral therapy.

23 Nov 2021

Success of covid antiviral pills hinges on access to speedy and accurate tests

Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.

22 Nov 2021

First long-acting injectable HIV treatment appraised and approved by NICE

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

19 Nov 2021

Antiretroviral News and Research

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

UTEP to develop new initiative to reduce HIV in people who use drugs in the El Paso-Ciudad Juárez border

New insights about COVID-19 vaccination rates among people living with HIV

Immune responses against SARS-CoV-2 Delta variant after BNT162b2 vaccination in people living with HIV

Children and other patients in Africa missed vital medical appointments due to COVID-19

Study analyzes global COVID-19 vaccination rates among people living with HIV

WHO recommends the use of first long-acting option to protect women from HIV

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

Scientists identify a new therapeutic target for HIV

Substantial efforts needed to help people with HIV achieve durable viral suppression, study suggests

Research finds low global HIV viral suppression rates among children and adolescents

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

Improving access to health care is key to reducing HIV incidence

Time of starting antiretroviral therapy can influence tumor development In HIV patients

Success of covid antiviral pills hinges on access to speedy and accurate tests

First long-acting injectable HIV treatment appraised and approved by NICE

LSHTM expert comments on NICE approval of first long-acting injectable HIV treatment

Antiretroviral drugs detected in drinking water

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News